Eximis CS System for Keyhole Surgery
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinator or your doctor.
How is the Eximis CS System treatment different from other treatments for keyhole surgery?
What is the purpose of this trial?
The purpose of this study is to evaluate device safety and effectiveness of the Eximis CS System.
Research Team
Scott Chudnoff, MD
Principal Investigator
Maimonides Medical Center
Eligibility Criteria
This trial is for individuals scheduled for keyhole surgery, specifically a laparoscopic hysterectomy or myomectomy. Participants must have completed pre-operative evaluations and consent to follow the study's procedures. They should have tissue specimens larger than 6 cm but not exceeding 13 cm in length.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo laparoscopic hysterectomy or myomectomy using the Eximis CS System for containment, segmentation, and extraction of uterine tissue
Follow-up
Participants are monitored for safety and effectiveness after the procedure
Treatment Details
Interventions
- Eximis CS (Contained Segmentation) System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eximis Surgical
Lead Sponsor
Proxima Clinical Research
Collaborator
Proxima CRO
Industry Sponsor